Takeda Agrees To Pay Texas $42M Over ADHD Drug Marketing

By Madeline Lyskawa · August 8, 2023, 4:51 PM EDT

The Texas Attorney General's Office said Tuesday that it has reached a $42.7 million settlement with six Takeda Pharmaceutical Co. subsidiaries, including Takeda Pharmaceuticals U.S.A. Inc. and Baxter International Inc., in...

To view the full article, register now.